mushroom

Molecular Assemblies Closes Oversubscribed $24 Million Series A Financing to Advance Enzymatic DNA Synthesis toward Initial Commercial Access

DNA synthesis

Home » Emerging technologies » DNA synthesis » Page 2

TdT

Ansa Biotechnologies partners with TeselaGen Biotechnology to enable commercial production of DNA products

mushroom

Ansa Biotechnologies Raises $9.2 Million in Combined Seed and Pre-Seed Financing

Evonetix

Evonetix and Analog Devices Collaborate on Third-Generation DNA Synthesis Platform

Emily Leproust, CEO, and Aaron Sato, CSO of Twist Bioscience. TWIST BIOSCIENCE

How A Newly Public Synthetic Biology Company Pivoted To The Pandemic: Up Close And Personal With Twist Bioscience

mushroom

Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use

mushroom

DNA Script Expands Series B to $89M

mushroom

Twist Bioscience Appoints Erin Smith Senior Vice President, Government Affairs and Public Policy

mushroom

Life Sciences Heavyweight, Dr Joe Keegan, Joins Fast Growing Nuclera’s Board as Non-executive Director

mushroom

Takeda Partners with Twist Bioscience to Expand Biologics Discovery Capabilities

DNA

A New Way Of Making DNA Is About To Revolutionize The Biotech Industry